FFM
MRK icon

Fullerton Fund Management’s Merck MRK Stock Holding History

Fullerton Fund Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$570K Buy
4,433
+815
+23% +$95.4K 0.04% 67
2026
Q1 		$435K Sell
3,618
-6,733
-65% -$777K 0.03% 75
2025
Q4 		$1.09M Buy
+10,351
New +$972K 0.05% 38
2024
Q2 		– Sell
-2,909
Closed -$384K – 164
2024
Q1 		$384K Buy
+2,909
New +$359K 0.02% 102

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fullerton Fund Management's MRK Position: Q2 2026 in Review

Fullerton Fund Management increased its Merck (MRK) stake by 23% in Q2 2026, buying an estimated $95.4K and bringing the position to 4,433 shares worth $570K. The position accounts for 0.04% of the portfolio, ranked #67.

Fullerton Fund Management first reported a position in MRK in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.09M in Q4 2025. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Fullerton Fund Management held 4,433 shares of Merck worth $570K as of Q2 2026.
  • Fullerton Fund Management bought 815 Merck shares in Q2 2026, an estimated $95.4K.
  • Merck made up 0.04% of Fullerton Fund Management's portfolio in Q2 2026, its #67 holding.
  • Fullerton Fund Management first reported a position in Merck in Q1 2024 and has held it in 4 quarters since.
  • Fullerton Fund Management's Merck position peaked at $1.09M in Q4 2025.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Fullerton Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.